AiCuris Provides Corporate Update
AiCuris Anti-infective Cures GmbH today provided a strategic update, outlining its recent achievements and plans for future growth.
AiCuris Anti-infective Cures GmbH today provided a strategic update, outlining its recent achievements and plans for future growth.
Event provides a perfect partnering platform to exchange with industry executives and
Cooperation focused on the joint development and optimization of human anti-infective drug candidates against gram-negative and gram-positive bacteria in relevant indications using Lysando’s Artilysin®s technology platform
If you have a media enquiry or further questions regarding public relation activities at AiCuris please contact:
Katja Woestenhemke
Management Assistant
AiCuris Anti-infective Cures GmbH
Friedrich-Ebert-Str. 475
42117 Wuppertal
Phone: +49 (0)202 317 63 - 0
Fax: +49 (0)202 317 63 - 1177
E-Mail: press@aicuris.com